Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
marcella.visentini@uniroma1.it
Marcella Visentini
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
marcella.visentini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells
IMMUNOLOGY LETTERS
2018
Persistence of pathogenic B cell clones and relapse of cryoglobulinemic vasculitis in HCV-cured patients
GASTROENTEROLOGY
2018
Switched CD21–/low B cells with an antigen-presenting phenotype in the infant thymus
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
2018
Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis
CLINICAL RHEUMATOLOGY
2017
Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia.
BLOOD
2017
From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?
EXPERT REVIEW OF HEMATOLOGY
2017
Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy Reply
HEPATOLOGY
2017
Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2016
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia
HEPATOLOGY
2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
BLOOD
2016
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy.
HEPATOLOGY
2015
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review
AUTOIMMUNITY REVIEWS
2015
Intravenous Immunoglobulin and Immunomodulation of B-Cell - in vitro and in vivo Effects
FRONTIERS IN IMMUNOLOGY
2015
Editorial: Immunoglobulin therapy in the 21st century - The dark side of the moon
FRONTIERS IN IMMUNOLOGY
2015
« prima
< precedente
1
2
3
4
Progetti di Ricerca
Pneumococcal vaccine for atherosclerosis: untangling the role of human marginal-zone B cells
Long-term outcomes of interferon-free antiviral therapy for hepatitis C virus-related lymphoproliferative disorders: biomarkers predictive of persistence or relapse
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma